ASSEMBLY BIOSCIENCES, INC. (ASMB) Corporate Subsidiaries
ASSEMBLY BIOSCIENCES, INC. (ASMB) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ASMB
CIK: 1426800
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerSara Macdonald
Audit LocationSan Jose, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| S-8 | 2026-08-20 | — | S-8 | 0001193125-26-359252 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001104659-26-097209 | View SEC Doc Filr Page |
| 8-K/A | 2026-08-14 | 2026-08-13 | 8-K/A | 0001193125-26-352193 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001193125-26-349236 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | 8-K | 0001193125-26-349198 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0001274173-26-000208 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-04 | — | SCHEDULE 13G/A Filing | 0000908834-26-000380 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-17 | 4 | 0001193125-26-275804 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-03-29 | 4 | 0001193125-26-259927 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-03-29 | 4 | 0001193125-26-259924 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | 4 | 0001193125-26-259855 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | 4 | 0001193125-26-259822 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | 4 | 0001193125-26-259808 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | 4 | 0001193125-26-259776 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | 4 | 0001193125-26-259742 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | 4 | 0001193125-26-259697 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-03-29 | 4 | 0001193125-26-259661 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-03-29 | 4 | 0001193125-26-259562 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-03-29 | 4 | 0001193125-26-259517 | View SEC Doc Filr Page |
| 8-K | 2026-06-05 | 2026-06-04 | 8-K | 0001193125-26-259481 | View SEC Doc Filr Page |
| 4 | 2026-05-27 | 2026-05-26 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001123292-26-000751 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-05-27 | — | SCHEDULE 13D/A Filing | 0001123292-26-000750 | View SEC Doc Filr Page |
| 8-K | 2026-05-26 | 2026-05-21 | 8-K | 0001193125-26-239277 | View SEC Doc Filr Page |
| 424B5 | 2026-05-26 | — | 424B5 | 0001193125-26-237361 | View SEC Doc Filr Page |
| 424B5 | 2026-05-22 | — | 424B5 | 0001193125-26-236812 | View SEC Doc Filr Page |